Resibufogenin inhibits the growth of human osteosarcoma MG-63 cells via mitochondrial pathway

  • Yue Zhang Department of Orthopedics, Second Affiliated Hospital, Zhejiang University, Hangzhou 310009
  • Ren-Fu Quan Department of Orthopedics, Xiaoshan Traditional Chinese Medical Hospital, Zhejiang University, Hangzhou 311201
  • Wei-Shan Cheng Department of Orthopedics, Second Affiliated Hospital, Zhejiang University, Hangzhou 310009
  • Zhao-Ming Ye Department of Orthopedics, Second Affiliated Hospital, Zhejiang University, Hangzhou 310009
  • Wei-Xu Li Department of Orthopedics, Second Affiliated Hospital, Zhejiang University, Hangzhou 310009
  • Di-Sheng Yang Department of Orthopedics, Second Affiliated Hospital, Zhejiang University, Hangzhou 310009
Keywords: Apoptosis, MG-63 cell, Osteosarcoma, Resibufogenin

Abstract

Resibufogenin, a low molecular weight bufanolide steroid compound, is isolated from the secretion of Asiatic toad Bufogargarizansa Cantor. It possessed both pharmacological and toxicological effects that were experimentally shown by in vitro and in vivo studies. However, the molecular mechanism of cell apoptosis induced by resibufogenin remains elusive. Here, we investigated the apoptosis in resibufogenin-treated human osteosarcoma MG-63 cells. The results showed that resibufogenin could inhibit cell proliferation and induce apoptosis in a dose- and time-dependent manner. Additional investigations proved that a disruption of mitochondrial transmembrane potential and an up-regulation of reactive oxygen species (ROS) in resibufogenin-treated cells were occurred. Upon western blot analysis, it was found that the up-regulation of Apaf-1, cleaved PARP, cleaved caspase-3, cleaved caspase-9, and Bax/Bcl-2, varied with different concentration of resibufogenin. Overall findings suggested that resibufogenin could be used as an effective anti-tumor agent in therapy of osteosarcoma.

Downloads

Download data is not yet available.
Abstract
1360
Download
517 Read
521

References

Aljubran AH, Griffin A, Pintilie M, Blackstein M. Osteosarcoma in adolescents and adults: Survival analysis with and without lung metastases. Ann Oncol. 2009; 20: 1136-41.

Brubacher JR, Lachmanen D, Ravikumar PR, Hoffman RS. Efficacy of digoxin specific Fab fragments (Digibind) in the treatment of toad venom poisoning. Toxicon 1999; 37: 931-42.

Chen KK, Korarikova A. Pharmacology and toxicology of toad venom. J Pharm Sci. 1967; 56: 1535-41.

Chow L, Johnson M, Wells A, Dasgupta A. Effect of the traditional Chinese medicines. Chan Su, Lu-Shen-Wan, Dan Shen, and Asian ginseng on serum digoxin measurement by Tinaquant (Roche) and Synchron LX system (Beckman) digoxin immunoassays. J Clin Lab Anal. 2003; 17: 22-27.

Dasgupta A, Biddle DA, Wells A, Datta P. Positive and negative interference of the Chinese medicine Chan Su in serum digoxin measurement: Elimination of interference by using a monoclonal chemiluminescent digoxin assay or monitoring free digoxin concentration. Am J Clin Pathol. 2000; 114: 174-79.

Gorlick R, Anderson P, Andrulis I. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: Meeting summary. Clin Cancer Res. 2003; 9: 5442-53.

Groopman JD, Zhu ZQ, Donahue PR, Pikul A, Zhang LS, Chen JS, Wogan GN. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res. 1992; 52: 4634-41.

Hong Z, Chen K, Yeung HW. Simultaneous determination of bufadienolides in the Traditional Chinese Medicine preparation, Liu-Shen-Wan, by liquid chromatography. J Pharm Pharmacol. 1992; 44: 1023-26.

Hirsch T, Marzo I, Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep. 1997; 17: 67-76.

Iannolo G, Conticello C, Memeo L, DeMaria R. Apoptosis in normal and cancer stem cells. Crit Rev Oncol Hematol. 2008; 66: 42-51.

Iwatsuki K, Yusa T, Kataoka Y, Sate K. Experimental and clinical studies of resibufogenin. Tohoku J Exp Med. 1965; 86: 93-101.

Ko RJ, Greenwald MS, Louscutoff SM, Au AM, Apple BR. Kreutzer RA, Haddon WF, Jackson TY, Boo FO, Presicek G. Lethal ingestion of Chinese herbal tea containing ch'ansu. West J Med. 1996; 164: 71-75.

Leigh JM, Caldwell AD. Some effects of RBG: An aglycone of animal origin. J Pharmacol. 1969; 21: 707-09.

Li ZQ. Traditional Chinese medicine for primary liver cancer. World J Gastroenterol. 1998; 4: 360-64.

Li M, Kondo T, Zhao QL, Li FJ, Tanabe K, Arai Y, Zhou ZC, Kasuya M. Apoptosis induced by cadmium in human lymphoma U937 cells through Ca2+-calpain and caspase-mitochondria dependent pathways. J Biol Chem. 2000; 275: 39702-09.

Mohamad N, Gutierrez A, Nunez M, Cocca C, Martín G, Cricco G, Medina V, Rivera E, Bergoc R. Mitochondrial apoptotic pathways. Biocell. 2005; 29: 149-61.

Morishita S, Shoji M, Oguni Y, Ito C, Higuchi M, Sakanashi M. Pharmacological actions of "kyushin," a drug containing toad venom: cardiotonic and arrhythmogenic effects, and excitatory effect on respiration. Am J Chin Med. 1992; 20: 245-56.

Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: Implications forcell death. Annu Rev Pharmacol Toxicol. 2007; 47: 143-83.

Ta HT, Dass CR, Choong PF, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metast Rev. 2009; 28: 247-63.

Takahashi A, Masuda A, Sun M, Centonze VE, Herman B. Oxidative stress-induced apoptosis is associated with alterations in mitochondrial caspase activity and Bcl-2-dependent alterations in mitochondrial pH (pHm). Brain Res Bull. 2004; 62: 497-04.

Xie JT, Dey L, Wu JA, Lowell TK, Yuan CS. Cardiac toxicity of resibufogenin: Electrophysiological evidence. Acta Pharmacol Sin. 2001; 22: 289-97.

Yeh JY, Huang WJ, Kan SF, Wang PS. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 2002; 54: 112-24.

Ye M, Ning L, Zhan J, Guo H, Guo D. Biotransformation of cinobufagin by cell suspension cultures of Catharanthus roseus and Platycodon grandiflorum. J Mol Catal B: Enzymatic 2003; 22: 89-95.

Yin XM. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res. 2000; 10: 161-67.

Zhang LS, Nakaya K, Yoshida T, Kuroiwa Y. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 1991; 178: 686-93.

Published
2014-09-03
How to Cite
Zhang, Y., R.-F. Quan, W.-S. Cheng, Z.-M. Ye, W.-X. Li, and D.-S. Yang. “Resibufogenin Inhibits the Growth of Human Osteosarcoma MG-63 Cells via Mitochondrial Pathway”. Bangladesh Journal of Pharmacology, Vol. 9, no. 3, Sept. 2014, pp. 413-8, doi:10.3329/bjp.v9i3.19483.
Section
Research Articles